Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Smart ways to survive: PlaySide inks deal with Warner Bros subsidiary for multi-game license

  • In News
  • December 14, 2023
  • Alinda Gupta
Smart ways to survive: PlaySide inks deal with Warner Bros subsidiary for multi-game license

Video game developer PlaySide Studios (ASX: PLY), the studio behind popular games like “Dumb Ways to Die” and “Age of Darkness: Final Stand”, has signed a multi-game license deal with Warner Bros. Interactive Entertainment, a subsidiary of Warner Bros. Discovery, Inc.

The agreement grants PlaySide access to a well-known intellectual property, allowing the development of two PC/Console game titles. The development timelines align with PlaySide’s existing strategy for creating titles based on licensed intellectual property for the PC/Console platform.

PlaySide CEO Gerry Sakkas commented, “This agreement is a groundbreaking moment for PlaySide, the culmination of years of effort building relationships with Hollywood studios and investing in our PC and Console development expertise. It is also consistent with our plans to develop larger titles. We are huge fans of the IP we are working with and are thrilled to be entrusted with the task of bringing it to life for other fans.” 

PlaySide, recognised for both original intellectual property and comprehensive game development services, has collaborated with industry giants like Activision Blizzard, Meta, Netflix Games, and Take Two Interactive.

Under the agreement, PlaySide will make multiple license payments to Warner Bros. Interactive Entertainment during the development phase, followed by a royalty structure based on the games’ revenue throughout the agreement’s five-year term from the release of the second title.

Sakkas emphasised, “We are proud to be partnering with Warner Bros. Interactive Entertainment, which has a longstanding history of supporting the extension of its franchises such as Batman into video games and has enjoyed recent success with the likes of Hogwart’s Legacy. I look forward to sharing more details with you soon.”

In its Q1 FY24 report, PlaySide reported a record quarterly revenue of $15.5 million, reflecting a substantial 140% increase compared to the previous year’s $6.5 million. Original IP revenue reached $6.6 million, with notable developments including the initiation of their Dumb Ways to Die VR title for Meta and the production of the PC/Console title Project Phoenix. During an AGM address, Sakkas projected a robust growth of approximately 50% in revenue compared to the previous record year.

PlaySide’s optimistic forecast positions the Company for EBITDA and operating cash flow positivity in the December quarter of FY24, with revenue expectations in the range of $55-60 million. This financial strength lays the groundwork for increased investment in original IP titles in the latter half of the fiscal year, extending into FY25.

Development on the first title under the Warner Bros. Interactive Entertainment agreement is set to commence immediately, with a joint announcement detailing the intellectual property and game specifics anticipated in the first half of 2024.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx ply
  • dumb ways to die
  • gerry sakkas
  • hogwarts legacy
  • playside studios
  • warner bros
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.